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Data were analyzed through a Numbers program 
to obtain the mean and the mode. 
Descriptive statistic was utilized.  
 
The literature reveals that pharmacological intervention is effective in reducing the 
relapse rate among opioid addiction disorder. Non-Pharmacological interventions 
include: cognitive behavior, social networking therapy, and collaborative 
intervention. Better outcome if combined
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Interventions 
● According to MayoClinic opioid use disorder defined as physical and psychological 
reliance on opioids, a substance found in certain prescription pain medications and 
illegal drugs like heroin(Mayo Clinic.  2019).
● The Center for Disease and Control Prevention(CDC) raised an alarm of the 
increased death from an opioid overdose in the United States and estimated from 
1999 to 2017, more than 700,000 people have died from a drug overdose(CDC. 2018). 
● The CDC also estimates  68% more than 70200 drug overdose death occurs in 2017 
alone(CDC. 2018). 
● The CDC indicated that the increase of death in 2017 it goes back to the nature of 
the opioid available in the market which was fentanyl which is six times higher than 
in 1999(CDC. 2018).
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Methods
To identify effective interventions  in maintaining 
long-term recovery from opioid dependency.
Conceptual Framework:
 Health Promotion Model.
The HPM will lead to a course of actions 
likely will lead to the desired outcome, and 
these desired outcomes will be a positive 
personal value.
Inclusion criteria:
 full text only, 2018-2019, Randomized 
clinical trial.
           Exclusion criteria:
       More than 1 year, non randomized control 
trials, substance abuse other than opioid
Search Keywords:
Interventions for opioid addiction 
Discussion 
The total of 8 articles from quantitative RCT.
The total sample size for all eight studies participants (N=3903).
Women (n=906) and 3,610 are men (n=2997).
The average age is 41.5 ranging from 18-65 years old. 
The research studies conduction sites: United States (n=6)  United Kingdom (n=1),  
China (n=1).
Strengths: This systematic review utilized the John Hopkins Nursing 
Evidence-Based Practice Research Evidence Appraisal to evaluate the eight studies 
of randomized clinical trials and determine the strength and quality of each study. 
Evidence strengths: level 1 and quality A.
Limitations: The research studies used different instruments to measure the 
effectiveness of opioid use disorder prevention which leads to lack of the 
inconsistency of the outcome
Behavioral Activation Treatment.
Brief Social Behavior, and Network Therapy.
Collaborative Care Interventions.
Pharmacological Management with Extended-release 
Naltrexone and Buprenorphine.
Family support.
Methods &
Sample size 
Data Quality 
and Strength 
Most important 
significant 
findings
Author(s)
/year
NTX/BUP
N=653
RCT
Strength Level: 1
Quality: A
 NTX/BUP  decreased opioid 
use with a P value 0.009.                          
     Bisaga, et al, 2018.  
Extended-release  Naltrexone
N=100
RCT
Strength Level: 1
Quality: A
Decreased opioid related 
behavior with a P value of 
0.05. 
Coffin, et al, 2018.
Behavioral activation treatment
N=263
RCT
Strength Level: 1
Quality: A
Significantly higher abstinence 
rates at three months with 95% 
confidence interval.
Daughters, et al, 2018
Social network-focused 
intervention.
N=83
RCT
Strength Level: 1
Quality: A
Abstinence from heroin 
confidence interval CI( 0.96).
Day, et al,2018
Extended release Naltrexone.
N=52
RCT
Strength Level: 1
Quality: A
Naltrexone group and a 
significant connectivity was 
significantly reduced over time 
in the participant randomize to 
Naltrexone but unchanged to 
the placebo group with the P 
value of 0.05.
Kohno, et al, 2018
Extended-release Naltrexone 
vs Buprenorphine-naloxone.
N=570
RCT
Strength Level: 1
Quality: A
The study finding concludes 
participants who receive 
extended-release NTX-BUP  
were more successfully 
inducted than in the extended 
release Naltrexone group with 
a P value of 0.001.
Lee, et al, 2018.
Collaborative care 
interventions. 
N=261
RCT
Strength Level: 1
Quality: A
Collaborative care increase 
both Initiation and Engagement 
among the full sample with a P 
value 0.001
Setodji, et al, 2108.
Family support
N=2446
RCT
Strength Level: 1
Quality: A
Less opioid use with family 
support with a P value of 0.002
Feng, et al, 2018.
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